Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Comparison Tests01:13

Multiple Comparison Tests

Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
Comparing Experimental Results: Student's t-Test01:09

Comparing Experimental Results: Student's t-Test

The t-test is a statistical method used to compare the sample mean with a population mean or compare two means from two data sets. The test statistic is calculated from the standard deviation, mean, and number of measurements in the data set at a selected confidence interval and then compared to a table of critical values at this confidence level. If the test statistic is smaller than the critical value, the null hypothesis is accepted. In this case, we state that the difference between the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An assessment of methods used in the investigation of iron status: findings in a population of young British South Asian children.

Journal of clinical pathology·2015
Same author

Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003.

British journal of haematology·2015
Same author

Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics.

British journal of haematology·2014
Same author

Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes.

Pharmacogenomics·2014
Same author

Utility of red cell distribution width in screening for iron deficiency.

Archives of disease in childhood·2013
Same author

Nomenclature for alleles of the thiopurine methyltransferase gene.

Pharmacogenetics and genomics·2013

Related Experiment Video

Updated: May 8, 2026

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

Implementation of TPMT testing.

Lynne Lennard1

  • 1Clinical Pharmacology Unit, Department of Human Metabolism, University of Sheffield, Sheffield, UK.

British Journal of Clinical Pharmacology
|August 22, 2013
PubMed
Summary

Thiopurine methyltransferase (TPMT) enzyme activity influences thiopurine drug efficacy and toxicity. TPMT testing before treatment identifies individuals at risk of severe side effects, ensuring safer drug use.

Keywords:
TPMTazathioprinechildhood leukaemiamercaptopurinethioguanine nucleotidesthiopurine methyltransferase

More Related Videos

TMT Sample Preparation for Proteomics Facility Submission and Subsequent Data Analysis
07:44

TMT Sample Preparation for Proteomics Facility Submission and Subsequent Data Analysis

Published on: June 8, 2020

Related Experiment Videos

Last Updated: May 8, 2026

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test
08:07

Traditional Trail Making Test Modified into Brand-new Assessment Tools: Digital and Walking Trail Making Test

Published on: November 23, 2019

TMT Sample Preparation for Proteomics Facility Submission and Subsequent Data Analysis
07:44

TMT Sample Preparation for Proteomics Facility Submission and Subsequent Data Analysis

Published on: June 8, 2020

Area of Science:

  • Pharmacogenetics
  • Clinical enzymology

Background:

  • Thiopurine drugs (azathioprine, mercaptopurine, thioguanine) are substrates for thiopurine methyltransferase (TPMT).
  • Genetic polymorphism in TPMT affects enzyme activity, with 1 in 300 lacking activity and 11% having intermediate activity.
  • TPMT deficiency is linked to severe myelosuppression and idiosyncratic drug reactions.

Purpose of the Study:

  • To review factors influencing TPMT enzyme activity and its measurement.
  • To highlight the importance of accurate TPMT status classification for thiopurine therapy.
  • To discuss the clinical adoption and cost-effectiveness of TPMT testing.

Main Methods:

  • Review of factors affecting TPMT enzyme activity.
  • Discussion of TPMT genotype-phenotype concordance.
  • Analysis of clinical recommendations and cost-effectiveness.

Main Results:

  • TPMT deficiency confers a high risk of severe bone marrow toxicity with standard thiopurine doses.
  • Heterozygotes face an increased risk of myelosuppression.
  • Concordance between TPMT genotype and phenotype is not always 100%, especially for intermediate activities.

Conclusions:

  • TPMT testing is crucial for identifying individuals at risk before initiating thiopurine therapy.
  • Testing is cost-effective and widely available, with varying adoption across specialties.
  • Mandatory testing is recommended, particularly for childhood leukemia treatment with mercaptopurine.